Anderson L A, Murray L J, Murphy S J, Fitzpatrick D A, Johnston B T, Watson R G P, McCarron P, Gavin A T
Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, The Queen's University Belfast, UK.
Gut. 2003 Aug;52(8):1081-4. doi: 10.1136/gut.52.8.1081.
Patients with Barrett's oesophagus have an increased risk of oesophageal adenocarcinoma but this cancer only accounts for a small proportion of deaths in these patients. Other causes of death are reportedly raised in this group. We examined cause specific mortality among individuals in a population based Barrett's oesophagus register.
We constructed a register of all patients diagnosed with columnar mucosa (including specialised intestinal metaplasia) of the oesophagus within Northern Ireland between 1993 and 1999. Deaths occurring within this cohort until 31 December 2000 were identified and mortality rates were compared with the general population.
Overall mortality was not raised in Barrett's patients. During 7413 person years of follow up in 2373 patients there were 253 deaths (standardised mortality ratio (SMR) 96 (95% confidence interval (CI) 84-107)). Mortality from oesophageal cancer was raised in patients with specialised intestinal metaplasia (SMR 774 (95% CI 317-1231)) but only 4.7% of patients died from this cancer. Mortality from stroke (SMR 65 (95% CI 37-93)) was significantly lower than the general population while mortality from non-cancerous digestive system diseases was significantly higher (SMR 211 (95% CI 111-311)). Mortality rates from all other causes were similar to those of the general population.
This study demonstrates that the overall mortality rate in patients with Barrett's oesophagus is closely similar to that of the general population. Oesophageal cancer mortality was raised but is an uncommon cause of death in these patients who also appear to have a reduced risk of death from stroke.
巴雷特食管患者患食管腺癌的风险增加,但这种癌症在这些患者的死亡原因中仅占一小部分。据报道,该群体中其他死因有所增加。我们在一个基于人群的巴雷特食管登记处调查了个体的特定病因死亡率。
我们建立了一个登记册,记录了1993年至1999年期间北爱尔兰所有被诊断患有食管柱状黏膜(包括特殊肠化生)的患者。确定了该队列中截至2000年12月31日发生的死亡情况,并将死亡率与普通人群进行比较。
巴雷特食管患者的总体死亡率并未升高。在2373例患者的7413人年随访期间,有253例死亡(标准化死亡率(SMR)为96(95%置信区间(CI)84 - 107))。特殊肠化生患者的食管癌死亡率升高(SMR为774(95%CI 317 - 1231)),但只有4.7%的患者死于这种癌症。中风死亡率(SMR为65(95%CI 37 - 93))显著低于普通人群,而非癌性消化系统疾病的死亡率则显著高于普通人群(SMR为211(95%CI 111 - 311))。所有其他原因的死亡率与普通人群相似。
本研究表明,巴雷特食管患者的总体死亡率与普通人群非常相似。食管癌死亡率升高,但在这些患者中是一种不常见的死亡原因,而且他们死于中风的风险似乎也有所降低。